LAURA ROGERS: Open Payments
NPI 1558872929 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 76 payments from 17 companies in 2025. Trend: 2023 $1,065 · 2024 $1,417 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $494 |
| Janssen Biotech, Inc. | 10 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $153 |
| Regeneron Healthcare Solutions, Inc. | 5 | $145 |
| Gilead Sciences, Inc. | 6 | $111 |
| Lilly USA, LLC | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 4 | $59 |
| Intercept Pharmaceuticals, Inc. | 3 | $54 |
| Ardelyx, Inc. | 2 | $52 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
Products named: RINVOQ, TREMFYA, DUPIXENT, ENTYVIO, OMVOH, MAVYRET, LINZESS, EOHILIA.
Industry payments across MS — which companies pay providers there.
